189 related articles for article (PubMed ID: 24101197)
1. Bone marrow deficiency of TRPC3 channel reduces early lesion burden and necrotic core of advanced plaques in a mouse model of atherosclerosis.
Tano JY; Solanki S; Lee RH; Smedlund K; Birnbaumer L; Vazquez G
Cardiovasc Res; 2014 Jan; 101(1):138-44. PubMed ID: 24101197
[TBL] [Abstract][Full Text] [Related]
2. Reduced Necrosis and Content of Apoptotic M1 Macrophages in Advanced Atherosclerotic Plaques of Mice With Macrophage-Specific Loss of Trpc3.
Solanki S; Dube PR; Birnbaumer L; Vazquez G
Sci Rep; 2017 Feb; 7():42526. PubMed ID: 28186192
[TBL] [Abstract][Full Text] [Related]
3. Reduced endoplasmic reticulum stress-induced apoptosis and impaired unfolded protein response in TRPC3-deficient M1 macrophages.
Solanki S; Dube PR; Tano JY; Birnbaumer L; Vazquez G
Am J Physiol Cell Physiol; 2014 Sep; 307(6):C521-31. PubMed ID: 25031020
[TBL] [Abstract][Full Text] [Related]
4. Reduced calcification and osteogenic features in advanced atherosclerotic plaques of mice with macrophage-specific loss of TRPC3.
Dube PR; Chikkamenahalli LL; Birnbaumer L; Vazquez G
Atherosclerosis; 2018 Mar; 270():199-204. PubMed ID: 29290366
[TBL] [Abstract][Full Text] [Related]
5. Increased size and cellularity of advanced atherosclerotic lesions in mice with endothelial overexpression of the human TRPC3 channel.
Smedlund KB; Birnbaumer L; Vazquez G
Proc Natl Acad Sci U S A; 2015 Apr; 112(17):E2201-6. PubMed ID: 25870279
[TBL] [Abstract][Full Text] [Related]
6. Impairment of survival signaling and efferocytosis in TRPC3-deficient macrophages.
Tano JY; Smedlund K; Lee R; Abramowitz J; Birnbaumer L; Vazquez G
Biochem Biophys Res Commun; 2011 Jul; 410(3):643-7. PubMed ID: 21684255
[TBL] [Abstract][Full Text] [Related]
7. CD70 limits atherosclerosis and promotes macrophage function.
Winkels H; Meiler S; Smeets E; Lievens D; Engel D; Spitz C; Bürger C; Rinne P; Beckers L; Dandl A; Reim S; Ahmadsei M; Van den Bossche J; Holdt LM; Megens RT; Schmitt M; de Winther M; Biessen EA; Borst J; Faussner A; Weber C; Lutgens E; Gerdes N
Thromb Haemost; 2017 Jan; 117(1):164-175. PubMed ID: 27786334
[TBL] [Abstract][Full Text] [Related]
8. Early steatohepatitis in hyperlipidemic mice with endothelial-specific gain of TRPC3 function precedes changes in aortic atherosclerosis.
Smedlund K; Dube P; Vazquez G
Physiol Genomics; 2016 Aug; 48(8):644-9. PubMed ID: 27449657
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-3/granulocyte macrophage colony-stimulating factor receptor promotes stem cell expansion, monocytosis, and atheroma macrophage burden in mice with hematopoietic ApoE deficiency.
Wang M; Subramanian M; Abramowicz S; Murphy AJ; Gonen A; Witztum J; Welch C; Tabas I; Westerterp M; Tall AR
Arterioscler Thromb Vasc Biol; 2014 May; 34(5):976-84. PubMed ID: 24651678
[TBL] [Abstract][Full Text] [Related]
10. Deficiency of the T cell regulator Casitas B-cell lymphoma-B aggravates atherosclerosis by inducing CD8+ T cell-mediated macrophage death.
Seijkens TTP; Poels K; Meiler S; van Tiel CM; Kusters PJH; Reiche M; Atzler D; Winkels H; Tjwa M; Poelman H; Slütter B; Kuiper J; Gijbels M; Kuivenhoven JA; Matic LP; Paulsson-Berne G; Hedin U; Hansson GK; Nicolaes GAF; Daemen MJAP; Weber C; Gerdes N; de Winther MPJ; Lutgens E
Eur Heart J; 2019 Jan; 40(4):372-382. PubMed ID: 30452556
[TBL] [Abstract][Full Text] [Related]
11. PDZK1 in leukocytes protects against cellular apoptosis and necrotic core development in atherosclerotic plaques in high fat diet fed ldl receptor deficient mice.
Yu P; Qian AS; Chathely KM; Trigatti BL
Atherosclerosis; 2018 Sep; 276():171-181. PubMed ID: 29853191
[TBL] [Abstract][Full Text] [Related]
12. Regulation of Csf1r and Bcl6 in macrophages mediates the stage-specific effects of microRNA-155 on atherosclerosis.
Wei Y; Zhu M; Corbalán-Campos J; Heyll K; Weber C; Schober A
Arterioscler Thromb Vasc Biol; 2015 Apr; 35(4):796-803. PubMed ID: 25810298
[TBL] [Abstract][Full Text] [Related]
13. Role of bone marrow-derived CC-chemokine receptor 5 in the development of atherosclerosis of low-density lipoprotein receptor knockout mice.
Potteaux S; Combadière C; Esposito B; Lecureuil C; Ait-Oufella H; Merval R; Ardouin P; Tedgui A; Mallat Z
Arterioscler Thromb Vasc Biol; 2006 Aug; 26(8):1858-63. PubMed ID: 16763157
[TBL] [Abstract][Full Text] [Related]
14. Allograft inflammatory factor-1 supports macrophage survival and efferocytosis and limits necrosis in atherosclerotic plaques.
Egaña-Gorroño L; Chinnasamy P; Casimiro I; Almonte VM; Parikh D; Oliveira-Paula GH; Jayakumar S; Law C; Riascos-Bernal DF; Sibinga NES
Atherosclerosis; 2019 Oct; 289():184-194. PubMed ID: 31439353
[TBL] [Abstract][Full Text] [Related]
15. Macrophage polarization by angiotensin II-type 1 receptor aggravates renal injury-acceleration of atherosclerosis.
Yamamoto S; Yancey PG; Zuo Y; Ma LJ; Kaseda R; Fogo AB; Ichikawa I; Linton MF; Fazio S; Kon V
Arterioscler Thromb Vasc Biol; 2011 Dec; 31(12):2856-64. PubMed ID: 21979434
[TBL] [Abstract][Full Text] [Related]
16. Bone marrow-specific deficiency of nuclear receptor Nur77 enhances atherosclerosis.
Hamers AA; Vos M; Rassam F; Marinković G; Kurakula K; van Gorp PJ; de Winther MP; Gijbels MJ; de Waard V; de Vries CJ
Circ Res; 2012 Feb; 110(3):428-38. PubMed ID: 22194623
[TBL] [Abstract][Full Text] [Related]
17. Nrf2 in bone marrow-derived cells positively contributes to the advanced stage of atherosclerotic plaque formation.
Harada N; Ito K; Hosoya T; Mimura J; Maruyama A; Noguchi N; Yagami K; Morito N; Takahashi S; Maher JM; Yamamoto M; Itoh K
Free Radic Biol Med; 2012 Dec; 53(12):2256-62. PubMed ID: 23051009
[TBL] [Abstract][Full Text] [Related]
18. Macrophage p53 controls macrophage death in atherosclerotic lesions of apolipoprotein E deficient mice.
Boesten LS; Zadelaar AS; van Nieuwkoop A; Hu L; Teunisse AF; Jochemsen AG; Evers B; van de Water B; Gijbels MJ; van Vlijmen BJ; Havekes LM; de Winther MP
Atherosclerosis; 2009 Dec; 207(2):399-404. PubMed ID: 19608184
[TBL] [Abstract][Full Text] [Related]
19. Macrophage p53 deficiency leads to enhanced atherosclerosis in APOE*3-Leiden transgenic mice.
van Vlijmen BJ; Gerritsen G; Franken AL; Boesten LS; Kockx MM; Gijbels MJ; Vierboom MP; van Eck M; van De Water B; van Berkel TJ; Havekes LM
Circ Res; 2001 Apr; 88(8):780-6. PubMed ID: 11325869
[TBL] [Abstract][Full Text] [Related]
20. Egr-1 deficiency in bone marrow-derived cells reduces atherosclerotic lesion formation in a hyperlipidaemic mouse model.
Albrecht C; Preusch MR; Hofmann G; Morris-Rosenfeld S; Blessing E; Rosenfeld ME; Katus HA; Bea F
Cardiovasc Res; 2010 May; 86(2):321-9. PubMed ID: 20110335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
